{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:18:10Z","timestamp":1787786290076,"version":"build-2784847793"},"reference-count":72,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Fungitell"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The BDG assay is a non\u2013culture-based biomarker widely used in the diagnosis of invasive fungal infections, particularly among immunocompromised patients. Conventional diagnostic methods, including culture and histopathology, are limited by low sensitivity and delayed turnaround times, prompting increased reliance on adjunctive serologic markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>BDG, a conserved component of the fungal cell wall, is detectable in serum across multiple clinically relevant fungi, including Candida spp., Aspergillus spp., and Pneumocystis jirovecii, but is absent or minimally expressed in organisms such as Blastomyces spp., Cryptococcus spp., and Mucorales. Multiple commercial BDG assays are available globally and differ in methodology, performance characteristics, and geographic availability, contributing to interassay variability and challenges in interpretation. Diagnostic performance also varies by pathogen and host population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Optimal use of BDG requires integration into a structured diagnostic framework incorporating host risk factors, imaging, microbiology, and complementary fungal biomarkers. Diagnostic stewardship is essential, as testing in low pretest probability settings reduces positive predictive value and may lead to inappropriate antifungal use. Emerging simplified assay formats and improved diagnostic algorithms may enhance turnaround time and clinical applicability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Overall, BDG is a valuable but imperfect adjunctive biomarker whose most promising utility lies in supporting clinical decision-making and antifungal stewardship in appropriately selected high-risk populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/clinchem\/hvag108","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:40:02Z","timestamp":1785843602000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical Utility and Diagnostic Performance of (1\u21923)-\u03b2-D-Glucan in Invasive Mycoses"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9682-3911","authenticated-orcid":false,"given":"Lili","family":"Tao","sequence":"first","affiliation":[{"name":"Department of Pathology, Microbiology and Immunology, Vanderbilt University , Nashville, TN ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1166-2563","authenticated-orcid":false,"given":"Sean Xiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine , Baltimore, MD ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5871-3933","authenticated-orcid":false,"given":"Philippe J","family":"Dufresne","sequence":"additional","affiliation":[{"name":"Institut National de Sante Publique du Quebec , Mycologie m\u00e9dicale (identification et r\u00e9sistance), Qu\u00e9bec City, QC ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6175-6755","authenticated-orcid":false,"given":"Anisha","family":"Misra","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Diagnostics Institute, Cleveland Clinic , Cleveland, OH ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"2026082618435151400_hvag108-B1","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3390\/jof8121262","article-title":"Serum beta-D-glucan in the diagnosis of invasive fungal disease in neonates, children and adolescents: a critical analysis of current data","volume":"8","author":"Ferreras-Antolin","year":"2022","journal-title":"J Fungi"},{"key":"2026082618435151400_hvag108-B2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.clinmicnews.2025.01.001","article-title":"Maximizing the diagnostic potential of 1,3 \u03b2-D-glucan assays for invasive fungal infections","volume":"50","author":"Morjaria","year":"2025","journal-title":"Clin Microbiol Newsl"},{"key":"2026082618435151400_hvag108-B3","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1128\/CVI.00513-10","article-title":"Persistence of a positive (1,3)-\u03b2-D-glucan test after clearance of candidemia in hematopoietic stem cell transplant recipients","volume":"18","author":"Mikulska","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"2026082618435151400_hvag108-B4","doi-asserted-by":"crossref","first-page":"E122","DOI":"10.1111\/j.1469-0691.2012.03777.x","article-title":"Post-diagnostic kinetics of the (1\u21923)-\u03b2-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia","volume":"18","author":"Koo","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2026082618435151400_hvag108-B5","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/BF02471013","article-title":"A new method for the quantification of \u03b2-glucan in plasma and its application in the diagnosis of postoperative infection","volume":"20","author":"Yokota","year":"1990","journal-title":"Jpn J Surg"},{"key":"2026082618435151400_hvag108-B6","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1128\/JCM.00673-15","article-title":"Evaluation of a novel plasma (1,3)-\u03b2-D-glucan detection assay for diagnosis of candidemia in pediatric patients","volume":"53","author":"Liu","year":"2015","journal-title":"J Clin Microbiol"},{"key":"2026082618435151400_hvag108-B7","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/432470","article-title":"Multicenter clinical evaluation of the (1\u21923) \u03b2-D-glucan assay as an aid to diagnosis of fungal infections in humans","volume":"41","author":"Ostrosky-Zeichner","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2026082618435151400_hvag108-B8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jmii.2014.06.009","article-title":"A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-\u03b2-D-glucan for invasive fungal infection: focus on cutoff levels","volume":"48","author":"He","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"2026082618435151400_hvag108-B9","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.01691-22","article-title":"Comparison of three \u03b2-glucan tests for the diagnosis of invasive candidiasis in intensive care units","volume":"61","author":"Kritikos","year":"2023","journal-title":"J Clin Microbiol"},{"key":"2026082618435151400_hvag108-B10","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myaf050","article-title":"Performance of fungitell STAT point-of-care test for the diagnosis of invasive fungal diseases","volume":"63","author":"Cordier","year":"2025","journal-title":"Med Mycol"},{"key":"2026082618435151400_hvag108-B11","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00869-21","article-title":"Evaluation of the performance of the associates of cape cod STAT assay for the diagnosis of invasive fungal disease in critical-care patients with COVID-19","volume":"59","author":"White","year":"2021","journal-title":"J Clin Microbiol"},{"key":"2026082618435151400_hvag108-B12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/mmy\/myaa028","article-title":"Performance characteristics of Fungitell STATTM, a rapid (1\u21923)-\u03b2-D-glucan single patient sample in vitro diagnostic assay","volume":"59","author":"D\u2019Ordine","year":"2020","journal-title":"Med Mycol"},{"key":"2026082618435151400_hvag108-B13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0255172","article-title":"Efficacy of the new \u03b2-D-glucan measurement kit for diagnosing invasive fungal infections, as compared with that of four conventional kits","volume":"16","author":"Bamba","year":"2021","journal-title":"PLoS One"},{"key":"2026082618435151400_hvag108-B14","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00464-18","article-title":"Comparative analysis of the Wako \u03b2-glucan test and the Fungitell assay for diagnosis of candidemia and Pneumocystis jirovecii pneumonia","volume":"56","author":"Friedrich","year":"2018","journal-title":"J Clin Microbiol"},{"key":"2026082618435151400_hvag108-B15","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00322-19","article-title":"Beta-D-glucan for diagnosing Pneumocystis pneumonia: a direct comparison between the Wako \u03b2-glucan assay and the Fungitell assay","volume":"57","author":"Mercier","year":"2019","journal-title":"J Clin Microbiol"},{"key":"2026082618435151400_hvag108-B16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/jof9010006","article-title":"The comparative evaluation of the Fujifilm Wako \u03b2-glucan assay and Fungitell assay for diagnosing invasive fungal disease","volume":"9","author":"Singh","year":"2022","journal-title":"J Fungi"},{"key":"2026082618435151400_hvag108-B17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236095","article-title":"Comparative performance evaluation of Wako \u03b2-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases","volume":"15","author":"Carolis","year":"2020","journal-title":"PLoS One"},{"key":"2026082618435151400_hvag108-B18","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/mmy\/myx004","article-title":"An evaluation of the performance of the Dynamiker\u00ae Fungus (1-3)-\u03b2-D-Glucan Assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumonia","volume":"55","author":"White","year":"2017","journal-title":"Med Mycol"},{"key":"2026082618435151400_hvag108-B19","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s40121-022-00627-7","article-title":"Evaluation of the Dynamiker\u00ae fungus (1\u20133)-\u03b2-D-glucan assay for the diagnosis of invasive aspergillosis in high-risk patients with hematologic malignancies","volume":"11","author":"Siopi","year":"2022","journal-title":"Infect Dis Ther"},{"key":"2026082618435151400_hvag108-B20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10156-010-0198-6","article-title":"Clinical viability of Fungitell, a new (1\u21923)-\u03b2-D-glucan measurement kit, for diagnosis of invasive fungal infection, and comparison with other kits available in Japan","volume":"17","author":"Yoshida","year":"2011","journal-title":"J Infect Chemother"},{"key":"2026082618435151400_hvag108-B21","doi-asserted-by":"crossref","first-page":"9265","DOI":"10.3390\/ijms22179265","article-title":"Development of a method of measuring \u03b2-D-glucan and its use in preemptive therapy for invasive fungal infections","volume":"22","author":"Yoshida","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026082618435151400_hvag108-B22","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3961\/jpmph.2014.47.2.124","article-title":"Outdoor (1\u21923)-\u03b2-D-glucan levels and related climatic factors","volume":"47","author":"Hwang","year":"2014","journal-title":"J Prev Med Public Heal"},{"key":"2026082618435151400_hvag108-B23","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1080\/10807039.2018.1460578","article-title":"Seasonal variation in (1\u21923)-\u03b2-D-glucan levels with health risk assessment and related factors in indoor environments of microbiology laboratories","volume":"25","author":"Hwang","year":"2019","journal-title":"Hum Ecol Risk Assess: Int J"},{"key":"2026082618435151400_hvag108-B24","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.03276-20","article-title":"Challenges with utilizing the 1,3-beta-D-glucan and galactomannan assays to diagnose invasive mold infections in immunocompromised children","volume":"59","author":"Hsu","year":"2021","journal-title":"J Clin Microbiol"},{"key":"2026082618435151400_hvag108-B25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.15263\/jlmqa.2026.48.1.20","article-title":"Split-sample quality assurance for the (1,3)-\u03b2-D-glucan assay","volume":"48","author":"Cho","year":"2026","journal-title":"J Lab Med Qual Assur"},{"key":"2026082618435151400_hvag108-B26","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/cid\/ciq206","article-title":"\u03b2-D-Glucan assay for the diagnosis of invasive fungal infections: a meta-analysis","volume":"52","author":"Karageorgopoulos","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2026082618435151400_hvag108-B27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.rmed.2016.05.017","article-title":"Diagnostic value of (1\u21923)-\u03b2-D-glucan in bronchoalveolar lavage fluid for invasive fungal disease: a meta-analysis","volume":"117","author":"Shi","year":"2016","journal-title":"Respir Med"},{"key":"2026082618435151400_hvag108-B28","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jinf.2014.04.008","article-title":"The utility of bronchoalveolar lavage beta-D-glucan testing for the diagnosis of invasive fungal infections","volume":"69","author":"Rose","year":"2014","journal-title":"J Infect"},{"key":"2026082618435151400_hvag108-B29","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.02094-19","article-title":"Efficacy of cerebrospinal fluid beta-D-glucan diagnostic testing for fungal meningitis. a systematic review","volume":"58","author":"Davis","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2026082618435151400_hvag108-B30","article-title":"Detection of high cerebrospinal fluid levels of (1\u21923)-\u03b2-D-glucan in cryptococcal meningitis","volume":"1","author":"Rhein","year":"2014","journal-title":"Open Forum Infect Dis"},{"key":"2026082618435151400_hvag108-B31","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01909-17","article-title":"Diagnosing invasive candidiasis","volume":"56","author":"Clancy","year":"2018","journal-title":"J Clin Microbiol"},{"key":"2026082618435151400_hvag108-B32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3390\/jof11020149","article-title":"Species-specific sensitivity and levels of Beta-D-glucan for the diagnosis of candidemia\u2014a systematic review and meta-analysis","volume":"11","author":"Ullah","year":"2025","journal-title":"J Fungi"},{"key":"2026082618435151400_hvag108-B33","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1093\/cid\/ciaa1943","article-title":"Assessment of the role of 1,3-\u03b2-D-glucan testing for the diagnosis of invasive fungal infections in adults","volume":"72","author":"Lamoth","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026082618435151400_hvag108-B34","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2026082618435151400_hvag108-B35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/imj.15589","article-title":"Consensus guidelines for the diagnosis and management of invasive candidiasis in haematology, oncology and intensive care settings","volume":"51","author":"Keighley","year":"2021","journal-title":"Intern Med J"},{"key":"2026082618435151400_hvag108-B36","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1016\/S1473-3099(24)00749-7","article-title":"Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM","volume":"25","author":"Cornely","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"2026082618435151400_hvag108-B37","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cmi.2019.09.010","article-title":"Diagnostic accuracy of serum (1,3)-beta-D-glucan for neonatal invasive candidiasis: systematic review and meta-analysis","volume":"26","author":"Cohen","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2026082618435151400_hvag108-B38","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.cmi.2024.02.012","article-title":"Lower (1,3)-beta-D-glucan sensitivity and in vitro levels in Candida auris and Candida parapsilosis strains","volume":"30","author":"Mikulska","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"2026082618435151400_hvag108-B39","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3390\/jof8090921","article-title":"Sensitivity of serum beta-D-glucan in candidemia according to Candida species epidemiology in critically ill patients admitted to the intensive care unit","volume":"8","author":"Mikulska","year":"2022","journal-title":"J Fungi"},{"key":"2026082618435151400_hvag108-B40","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/cid\/cis456","article-title":"(1,3)-\u03b2-D-glucan as a prognostic marker of treatment response in invasive candidiasis","volume":"55","author":"Jaijakul","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2026082618435151400_hvag108-B41","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s13054-024-05022-x","article-title":"Prognostic value of serial (1,3)-\u03b2-D-glucan measurements in ICU patients with invasive candidiasis","volume":"28","author":"Carelli","year":"2024","journal-title":"Crit Care"},{"key":"2026082618435151400_hvag108-B42","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1128\/JCM.00773-12","article-title":"Correlation of clinical outcomes with \u03b2-glucan levels in patients with invasive candidiasis","volume":"50","author":"Sims","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2026082618435151400_hvag108-B43","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.cmi.2020.05.024","article-title":"Diagnostic accuracy of serum (1-3)-\u03b2-D-glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis","volume":"26","author":"Corpo","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2026082618435151400_hvag108-B44","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.713265","article-title":"A negative (1,3)-\u03b2-D-glucan result alone is not sufficient to rule out a diagnosis of Pneumocystis pneumonia in patients with hematological malignancies","volume":"12","author":"Damiani","year":"2021","journal-title":"Front Microbiol"},{"key":"2026082618435151400_hvag108-B45","article-title":"An overview of the laboratory diagnosis of Pneumocystis jirovecii pneumonia","volume":"63","author":"Cartagena","year":"2025","journal-title":"J Clin Microbiol"},{"key":"2026082618435151400_hvag108-B46","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/cid\/ciy1072","article-title":"Clinical performance of (1,3) beta-D glucan for the diagnosis of pneumocystis pneumonia (PJP) in cancer patients tested with PJP polymerase chain reaction","volume":"69","author":"Morjaria","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2026082618435151400_hvag108-B47","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myaf085","article-title":"Evaluation and clinical impact of the combination of Wako\u00ae (1,3)-\u03b2-D-glucan in serum and RT-PCR in oral wash for Pneumocystis jirovecii infection diagnosis: a retrospective cohort study","volume":"63","author":"Maldonado-Barrueco","year":"2025","journal-title":"Med Mycol"},{"key":"2026082618435151400_hvag108-B48","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3390\/jof11080555","article-title":"Emerging risk factors for invasive pulmonary aspergillosis: a narrative review","volume":"11","author":"Elkhapery","year":"2025","journal-title":"J Fungi"},{"key":"2026082618435151400_hvag108-B49","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"2026082618435151400_hvag108-B50","article-title":"Diagnostic performance of serum galactomannan and \u03b2-D-glucan for invasive aspergillosis in suspected patients: a meta-analysis","volume":"103","author":"Huang","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"2026082618435151400_hvag108-B51","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.diagmicrobio.2018.08.005","article-title":"The performance of galactomannan in combination with 1,3-\u03b2-D-glucan or aspergillus-lateral flow device for the diagnosis of invasive aspergillosis: evidences from 13 studies","volume":"93","author":"Zhang","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2026082618435151400_hvag108-B52","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1099\/jmm.0.47162-0","article-title":"Observations on (1-3)-\u03b2-D-glucan detection as a diagnostic tool in endemic mycosis caused by histoplasma or blastomyces","volume":"56","author":"Girouard","year":"2007","journal-title":"J Med Microbiol"},{"key":"2026082618435151400_hvag108-B53","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00005-20","article-title":"Practical guidance for clinical microbiology laboratories: antibody and antigen detection methods for dimorphic fungal infections","volume":"38","author":"Theel","year":"2025","journal-title":"Clin Microbiol Rev"},{"key":"2026082618435151400_hvag108-B54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.107360","article-title":"Fungal biomarkers in HIV-associated disseminated histoplasmosis: a multicenter diagnostic accuracy study on the Guiana shield","volume":"153","author":"Moussiegt","year":"2025","journal-title":"Int J Infect Dis"},{"key":"2026082618435151400_hvag108-B55","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac609","article-title":"Comparison of indirect fungal diagnostic tests in patients with proven histoplasmosis","volume":"9","author":"Krishnan","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"2026082618435151400_hvag108-B56","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1128\/JCM.43.12.5957-5962.2005","article-title":"Evaluation of a (1\u21923)-\u03b2-D-glucan assay for diagnosis of invasive fungal infections","volume":"43","author":"Pickering","year":"2005","journal-title":"J Clin Microbiol"},{"key":"2026082618435151400_hvag108-B57","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00663-18","article-title":"Detection of (1,3)-\u03b2-D-glucan in cerebrospinal fluid in histoplasma meningitis","volume":"56","author":"Myint","year":"2018","journal-title":"J Clin Microbiol"},{"key":"2026082618435151400_hvag108-B58","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1128\/JCM.00631-12","article-title":"Serum (1\u21923)-\u03b2-D-glucan measurement in coccidioidomycosis","volume":"50","author":"Thompson","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2026082618435151400_hvag108-B59","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3390\/jof11110814","article-title":"Diagnostic performance of coccidioidomycosis PCR testing in lung nodules: a retrospective study in Central California","volume":"11","author":"Nasrawi","year":"2025","journal-title":"J Fungi"},{"key":"2026082618435151400_hvag108-B60","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myad061","article-title":"Performance of the beta-glucan test for the diagnosis of invasive fusariosis and scedosporiosis: a meta-analysis","volume":"61","author":"Lamoth","year":"2023","journal-title":"Med Mycol"},{"key":"2026082618435151400_hvag108-B61","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/cid\/cir897","article-title":"\u03b2-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3)","volume":"54","author":"Lamoth","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2026082618435151400_hvag108-B62","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw128","article-title":"Prospective evaluation of serum \u03b2-glucan testing in patients with probable or proven fungal diseases","volume":"3","author":"Angebault","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"2026082618435151400_hvag108-B63","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/mmy\/myab016","article-title":"Prospective comparison of (1,3)-beta-D-glucan detection using colorimetric and turbidimetric assays for diagnosing invasive fungal disease","volume":"59","author":"Alanio","year":"2021","journal-title":"Med Mycol"},{"key":"2026082618435151400_hvag108-B64","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/cid\/ciw592","article-title":"Galactomannan, \u03b2-D-glucan, and polymerase chain reaction\u2013based assays for the diagnosis of invasive fungal disease in pediatric cancer and hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"63","author":"Lehrnbecher","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2026082618435151400_hvag108-B65","first-page":"43","article-title":"Pediatric reference intervals for biochemical markers: gaps and challenges, recent national initiatives and future perspectives\u2014PMC","volume":"28","author":"Tahmasebi","year":"2017","journal-title":"EJIFCC"},{"key":"2026082618435151400_hvag108-B66","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmicom.2025.105061","article-title":"Optimizing use of the (1-3)-\u03b2-D-glucan assay for the diagnosis of Pneumocystis jirovecii pneumonia","volume":"2","author":"Lee","year":"2025","journal-title":"CMI Commun"},{"key":"2026082618435151400_hvag108-B67","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy195","article-title":"Single academic center experience of unrestricted \u03b2-D-glucan implementation","volume":"5","author":"Fabre","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2026082618435151400_hvag108-B68","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae358","article-title":"A diagnostic stewardship intervention to improve utilization of 1,3 \u03b2-D-glucan testing at a single academic center: five-year experience","volume":"11","author":"Colson","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2026082618435151400_hvag108-B69","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) consensus group","volume":"46","author":"Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2026082618435151400_hvag108-B70","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/cid\/cit808","article-title":"Utility of (1\u20133)-\u03b2-D-glucan testing for diagnostics and monitoring response to treatment during the multistate outbreak of fungal meningitis and other infections","volume":"58","author":"Litvintseva","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2026082618435151400_hvag108-B71","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/cid\/ciad520","article-title":"Emerging roles of (1\u21923)-\u03b2-D-glucan in cerebrospinal fluid for detection and therapeutic monitoring of invasive fungal diseases of the central nervous system","volume":"78","author":"Walsh","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026082618435151400_hvag108-B72","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1128\/JCM.02301-14","article-title":"Utility of measuring (1,3)-\u03b2-D-glucan in cerebrospinal fluid for diagnosis of fungal central nervous system infection","volume":"53","author":"Lyons","year":"2014","journal-title":"J Clin Microbiol"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/clinchem\/advance-article-pdf\/doi\/10.1093\/clinchem\/hvag108\/70810486\/hvag108.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/clinchem\/advance-article-pdf\/doi\/10.1093\/clinchem\/hvag108\/70810486\/hvag108.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T22:44:05Z","timestamp":1787784245000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/advance-article\/doi\/10.1093\/clinchem\/hvag108\/8771480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":72,"URL":"https:\/\/doi.org\/10.1093\/clinchem\/hvag108","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"article-number":"hvag108"}}